A tendency towards mutual exclusivity between the loss or mutation of NF1 and amplification or mutation of EGFR was observed using Fisher's exact tests (Supplementary Table S7), indicating that both types of alteration may be sufficient to activate the RAS-RAF-MEK-MAPK cascade in RMPAhigh gliomas. The gene discussed is EGFR; the disease is glioma.